Company Valuation: Valiant Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2024 2025 2026
Market Cap 1 6,302 3,327 2,804
Change - -47.2% -15.74%
Enterprise Value (EV) 1 5,631 3,780 2,934
Change - -32.87% -22.38%
P/E 1,725x -150x -79.4x
PBR 2.66x 1.42x 0.9x
PEG -17.4x 0x -2.9x
Capitalization / Revenue 3.46x 2.49x 1.18x
EV / Revenue 3.09x 2.83x 1.24x
EV / EBITDA -65.5x -77.6x 43.2x
EV / EBIT -54.3x -55.8x 303x
EV / FCF -14.1x -2.79x -6.1x
FCF Yield -7.11% -35.9% -16.4%
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 0.0841 -0.51 -0.65
Distribution rate - - -
Net sales 1 1,821 1,334 2,375
EBITDA 1 -85.98 -48.7 67.99
EBIT 1 -103.7 -67.72 9.695
Net income 1 3.196 -22.01 -32.68
Net Debt 1 -671.1 452.9 130.6
Reference price 2 145.05 76.58 51.62
Nbr of stocks (in thousands) 43,450 43,450 54,313
Announcement Date 17/07/24 01/09/25 03/09/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 73.45M
40.09x5.41x21.97x0.96% 84.98B
34.4x5.19x22.18x1.86% 44.52B
24.33x2.88x15.07x2.15% 34.88B
15.57x1.61x9.03x2.67% 34.16B
39.22x7.05x18.7x1.58% 32.15B
14.93x1.42x8.79x2.14% 26.59B
39.32x9.52x29.22x2.26% 23.93B
26.29x2.83x11.52x1.71% 18.91B
7.39x2.14x4.25x3.53% 15.61B
Average 26.84x 4.23x 15.64x 2.1% 31.58B
Weighted average by Cap. 30.18x 4.51x 17.44x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Valiant Laboratories Limited

Historical PBR trend

Valuation ratios - PBR - Valiant Laboratories Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Valiant Laboratories Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Valiant Laboratories Limited

  1. Stock Market
  2. Stocks
  3. VALIANTLAB Stock
  4. Valuation Valiant Laboratories Limited